Aspirin-DOAC combo increases bleeding risk without extra thrombosis prevention

Aspirin use in combination with DOACs appears to increase the risk of bleeding in patients without providing any additional protection from thrombotic events. According to a US study presented at the 61st American Society of Haematology (ASH) annual meeting in Orlando, almost a third of patients (32%) on DOACs were also on aspirin without any ...

Already a member?

Login to keep reading.

© 2021 the limbic